Literature DB >> 15150687

[Devil's claw extract as an example of the effectiveness of herbal analgesics].

S Chrubasik1.   

Abstract

Preparations from devil's claw differ in their content of active ingredients as assessed by the quantity of harpagoside present. The harpagoside content in the daily dose of Doloteffin (extraction solvent water) is double that of preparations extracted with 60% ethanol. Only preparations with proven effectiveness for painful lower back or arthrotic pain are an attractive alternative to synthetic analgesics, and are of substantial benefit in the treatment of chronic pain. From an evidence based view, extract with at least 50 mg harpagoside in the daily dose should be recommended for the treatment of pain. Treatment with devil's claw extract is associated with a lower risk of adverse events than treatment with synthetic analgesics, and may contribute in the majority of patients to the relief of pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150687     DOI: 10.1007/s00132-004-0675-7

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  12 in total

1.  Current methods of the US Preventive Services Task Force: a review of the process.

Authors:  R P Harris; M Helfand; S H Woolf; K N Lohr; C D Mulrow; S M Teutsch; D Atkins
Journal:  Am J Prev Med       Date:  2001-04       Impact factor: 5.043

2.  [Antiarthritis effect of the Harpagophytum root; preliminary report].

Authors:  B ZORN
Journal:  Z Rheumaforsch       Date:  1958-04

3.  [Effects of Harpagophytum procumbens LI 174 (devil's claw) on sensory, motor und vascular muscle reagibility in the treatment of unspecific back pain].

Authors:  H Göbel; A Heinze; M Ingwersen; U Niederberger; D Gerber
Journal:  Schmerz       Date:  2001-02       Impact factor: 1.107

4.  Comparison of outcome measures during treatment with the proprietary Harpagophytum extract doloteffin in patients with pain in the lower back, knee or hip.

Authors:  S Chrubasik; J Thanner; O Künzel; C Conradt; A Black; S Pollak
Journal:  Phytomedicine       Date:  2002-04       Impact factor: 5.340

5.  Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens.

Authors:  M C Lanhers; J Fleurentin; F Mortier; A Vinche; C Younos
Journal:  Planta Med       Date:  1992-04       Impact factor: 3.352

6.  A survey on pain complaints and health care utilization in a German population sample.

Authors:  S Chrubasik; H Junck; H A Zappe; O Stutzke
Journal:  Eur J Anaesthesiol       Date:  1998-07       Impact factor: 4.330

Review 7.  The quality of clinical trials with Harpagophytum procumbens.

Authors:  S Chrubasik; C Conradt; A Black
Journal:  Phytomedicine       Date:  2003       Impact factor: 5.340

8.  A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain.

Authors:  S Chrubasik; A Model; A Black; S Pollak
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

9.  Effectiveness of Harpagophytum procumbens in treatment of acute low back pain.

Authors:  S Chrubasik; C Zimpfer; U Schütt; R Ziegler
Journal:  Phytomedicine       Date:  1996-05       Impact factor: 5.340

10.  Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis.

Authors:  P Chantre; A Cappelaere; D Leblan; D Guedon; J Vandermander; B Fournie
Journal:  Phytomedicine       Date:  2000-06       Impact factor: 5.340

View more
  1 in total

1.  Phytochemical Analysis and Anti-Inflammatory and Anti-Osteoarthritic Bioactive Potential of Verbascum thapsus L. (Scrophulariaceae) Leaf Extract Evaluated in Two In Vitro Models of Inflammation and Osteoarthritis.

Authors:  Giovanna Calabrese; Agata Zappalà; Anna Dolcimascolo; Rosaria Acquaviva; Rosalba Parenti; Giuseppe Antonio Malfa
Journal:  Molecules       Date:  2021-09-05       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.